Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8303 USD | -2.33% | -7.74% | -38.50% |
05-15 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-38.50% | 3.18M | |
-6.03% | 180B | |
+1.08% | 109B | |
-2.19% | 68.93B | |
-5.98% | 46.41B | |
+12.31% | 45.43B | |
+7.38% | 43.26B | |
+15.98% | 30.05B | |
+16.10% | 25.19B | |
-9.57% | 23.19B |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- INVO Bioscience, Inc. Appoints Dr. Kevin Doody to its Board of Directors